Novo Nordisk - Oxford Fellowship Programme
The Novo Nordisk – Oxford Fellowship Programme aims to support the development of a new generation of exceptional researchers in the field of diabetes and other cardiometabolic diseases, who will become future leaders in the field.
Contact us
-
Nuala Simpson
Research Facilitator and Novo Nordisk–Oxford Fellowship Programme Operations Manager
-
Serena Briant
Senior Research Facilitator and Novo Nordisk Programme Manager
Supported by
Our aim
The Novo Nordisk – Oxford Fellowship Programme is focused on research in diabetes, cardiometabolism, liver and renal disease. It aims to support the development of a new generation of exceptional early career researchers, who will become future leaders in the field, while further developing scientific excellence and ultimately improving the lives of patients. We offer prestigious 3-year postdoctoral research fellowship positions in research projects that span the translational spectrum, from basic biological research through to clinical application.
What we offer
We offer fellows a cutting edge research project based at the University of Oxford, which is supervised by world-leading researchers in the field of diabetes and other cardiometabolic diseases. In addition, each fellow is given a mentor or supervisor at Novo Nordisk. There is also the opportunity to spend time in the laboratories of Novo Nordisk (both in Oxford and Denmark). This distribution of time will depend on the fellow's specific project. Fellows will therefore get an insight into research in both academia and industry.
Latest publications
-
The perineurium integrates leptin with its sympathetic outflow to protect against obesity
Preprint
Sarker G. et al, (2024)
-
The Importance of Intra-Islet Communication in the Function and Plasticity of the Islets of Langerhans during Health and Diabetes.
Journal article
Hill TG. and Hill DJ., (2024), Int J Mol Sci, 25
-
Kisspeptin upregulates β-cell serotonin production during pregnancy.
Journal article
Hill TG. et al, (2024), J Endocrinol, 260
-
Compartment-based reconstruction of acquisition-weighted 31P cardiac MRSI reduces sensitivity to cardiac motion and scan planning
Journal article
Tyler A. et al, (2024), Frontiers in Physiology, 14